DDX53 and neoplasm: To assess the anti-tumor effect of Zbtb7b in the normal immune system, Zbtb7b-deficient (sgZbtb7b) CT26 and LLC cell lines were created, and in vivo experiments were conducted using normal immune BALB/c mice.